Form 4: StoneX CFO Executes Stock Option Exercise and Sale
Statement of Changes in Beneficial Ownership
StoneX Group Inc. CFO William J. Dunaway exercised 84,375 stock options and sold 63,602 shares of common stock.
Summary
- CFO William J. Dunaway exercised 84,375 stock options at a strike price of $13.34 per share.
- Following the exercise, the CFO sold 63,602 shares of common stock at an average price of $131.1596 per share.
- The transactions were executed pursuant to a Rule 10b5-1 trading plan.
- The CFO's total beneficial ownership of common stock stands at 294,359 shares following these transactions.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative transaction by an executive, which carries no significant signal regarding the company's operational health.
Positives
- The transaction was conducted under a pre-arranged Rule 10b5-1 plan, indicating a systematic approach to equity management rather than reactive selling.
- The CFO retains a significant equity stake of 294,359 shares, maintaining alignment with shareholder interests.
Negatives
- The sale of 63,602 shares represents a reduction in the CFO's direct holdings.
Risks
- Future share price volatility could impact the value of the remaining equity held by the executive.
Future Outlook
No specific forward-looking guidance regarding company operations was provided in this filing.
Management Comments
- The reporting person will provide full information regarding the number of shares sold at each separate price upon request.
Industry Context
StockSavvy.ai notes that insider selling via 10b5-1 plans is a standard practice for executives to manage personal liquidity and tax obligations, and is generally viewed as neutral by the market.
Comparison to Industry Standards
- The use of Rule 10b5-1 plans is the industry standard for C-suite executives at publicly traded financial services firms to avoid allegations of insider trading.
Stakeholder Impact
- Minimal impact expected as the transaction was pre-planned and represents a standard exercise of compensation-related equity.
Next Steps
- No further actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 2021-12-05 | Initial exercisability date of the stock options. |
| 2026-06-12 | Date of option exercise and subsequent share sale. |
| 2026-06-15 | Date of filing. |
| 2026-12-05 | Expiration date of the stock options. |
Keywords
StoneX Group, SNEX, Insider Trading, Form 4, CFO, Stock Options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.